Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (11)

2001

  1. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models

    Endocrine, Vol. 15, Núm. 2, pp. 241-248

1997

  1. Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7- 36)amide effects in liver and muscle

    Archives of Biochemistry and Biophysics, Vol. 341, Núm. 1, pp. 1-7

  2. GLP-1 (7-36) amide: Effects on glucose transport and metabolism in rat adipose tissue

    Hormone and Metabolic Research, Vol. 29, Núm. 9, pp. 417-421

  3. Preserved GLP-I effects on glycogen synthase α activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats

    Diabetes, Vol. 46, Núm. 8, pp. 1264-1269

1996

  1. Inositolphosphoglycans and diacylglycerol are possible mediators in the glycogenic effect of GLP-1(7-36)Amide in BC3H-1 myocytes

    Cell Biochemistry and Function, Vol. 14, Núm. 1, pp. 43-48

  2. Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7-36)amide action in the liver

    Journal of Endocrinological Investigation, Vol. 19, Núm. 2, pp. 114-118

1995

  1. Glucagon-like peptide-1 binding to rat hepatic membranes

    Journal of Endocrinology, Vol. 146, Núm. 1, pp. 183-189

  2. Glucagon-like peptide-1 binding to rat skeletal muscle

    Peptides, Vol. 16, Núm. 2, pp. 225-229

  3. Physiological effect of glucagon in human isolated adipocytes

    Hormone and Metabolic Research, Vol. 27, Núm. 8, pp. 372-375

1994

  1. Glucagon-like peptide 1: A potent glycogenic hormone

    FEBS Letters, Vol. 349, Núm. 2, pp. 313-316

  2. Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle

    Diabetologia, Vol. 37, Núm. 11, pp. 1163-1166